Large Geographic Variation Seen With Heart Failure Phenotypes
By Lori Solomon HealthDay Reporter
THURSDAY, July 18, 2024 -- There is substantial geographic variation in patient characteristics, treatment, and outcomes among patients with heart failure with preserved ejection fraction (HFpEF) or mildly reduced ejection fraction (HFmrEF), according to a study published online June 23 in the European Journal of Heart Failure.
Mingming Yang, from the University of Glasgow in the United Kingdom, and colleagues investigated geographic differences in HFpEF and HFmrEF across five global regions. The analysis included 19,959 patients (23.1 percent with HFmrEF).
The researchers found that regardless of HF phenotype, patients from Western Europe were oldest and those in Central/Eastern Europe and Russia were youngest. Latin America had the greatest portion of females, while North America had the most Black patients. In North America, obesity and diabetes were most prevalent, while hypertension and coronary heart disease most common in Central/Eastern Europe and Russia. Self-reported health status varied widely and was the worst in North America and best in Asia-Pacific. Rates of the primary composite end point (cardiovascular death or HF hospitalization) among patients with HFmrEF were 12.56 per 100 patient-years in North America, 11.67 in Asia-Pacific, 10.12 in Central/Eastern Europe and Russia, 8.90 in Latin America, and 8.43 in Western Europe. For HFpEF, the corresponding rates were 11.47, 7.80, 5.47, 5.92, and 7.80. The primary composite end point was driven by differences in the rate of HF hospitalization.
"These findings have implications for interpretation and generalizability of trial results, design and conduct of future trials, and optimization of care for these patients," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-19 05:15
Read more
- Quitting Smoking After Cancer Diagnosis Boosts Survival by Up to 26%
- Stereotactic Body Radiotherapy Viable Alternative for Localized Prostate Cancer
- Fish Oil Supplements Might Help Prevent Cancer
- Medicaid Covers GLP-1 Meds for Obesity in Just 13 States
- Avadel Pharmaceuticals Announces FDA Approval of Lumryz (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy
- CDC Confirms Second Human Bird Flu Case in Missouri With No Known Exposure to Farm Animals
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions